XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Statement of Comprehensive Income [Abstract]        
Revenue $ 1,421 $ 216 $ 2,620 $ 467
Operating expenses:        
Cost of goods sold (exclusive of depreciation and amortization) 3,001 2,202 6,038 9,600
Research and development 4,170 2,531 8,158 4,914
Selling, general and administrative 10,382 3,792 19,722 6,529
Depreciation and amortization 884 328 1,766 671
Total operating expenses 18,437 8,853 35,684 21,714
Operating loss (17,016) (8,637) (33,064) (21,247)
Other income (expense):        
Interest income (expense) 109 (3,077) 109 (5,858)
Change in fair value of warrants 17,763 (27,182) 24,150 (38,841)
Other income (loss), net (37) (66) (53) (69)
Income (loss) before income taxes 819 (38,962) (8,858) (66,015)
Benefit (provision) for income taxes 8 (13) (26) (28)
Net income (loss) 827 (38,975) (8,884) (66,043)
Foreign currency translation adjustment (9) 1 (22)
Comprehensive income (loss) 818 (38,974) (8,906) (66,043)
Net income (loss) 827 (38,975) (8,884) (66,043)
Change in redemption value of preferred interests (5,643) (13,831)
Net income (loss) attributable to common stockholders $ 827 $ (44,618) $ (8,884) $ (79,874)
Weighted average of shares outstanding – basic 101,071 7,346 99,886 7,346
Weighted average shares – diluted 102,381 7,346 99,886 7,346
Net income (loss) attributable to common stockholders per share - basic $ 0.01 $ (6.07) $ (0.09) $ (10.87)
Net income (loss) attributable to common stockholders per share - diluted $ 0.01 $ (6.07) $ (0.09) $ (10.87)